https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

Call IDIVAL-UC definitive resolution of applications admitted

22 de December de 2016

Director of the Institute Marques de Valdecilla (IDIVAL) and Vice-Chancellor of Research and Knowledge Transfer of the University of Cantabria resolve the call for aid for the contracts of the Research Staff Program in predoctoral training in the area of biomedicine, Biotechnology and health sciences.  Once the allegations submitted to the proposed provisional solution have […]

Read more →

Lilly Foundation Awards for Preclinical and Clinical Biomedical Research 2017

21 de December de 2016

The Lilly Foundation calls the Lilly Foundation Awards for Preclinical and Clinical Biomedical Research 2017, for researchers who have contributed significantly to the development of Biomedicine and Health Sciences in Spain, and maintain an activity of recognized scientific level. The objective is to promote high-quality, preclinical and clinical Biomedical Research through the awarding of Prizes […]

Read more →

Biomarker tools to design clinical vaccines determined from a study of annual listeriosis

19 de December de 2016

Frontiers in Immunology, the first most cited magazine in the field of Immunology and with high ranking, publishes in its open-access edition a coordinated work between the IDIVAL Research Institute (Group of Nanovacunas and cellular vaccines based on Listeria), Marqués de Valdecilla University Hospital (Microbiology Service and Section of Infectious Diseases) and the University Hospital […]

Read more →

IDIVAL resolves calls for projects for young researchers innovation and intensification projects

14 de December de 2016

IDIVAL calls an Annual Programme of Grants to foster research and these grants promote mainly training, talent capture, innovation and internationalization. These programmes are: 1- Post MIR Valdecilla Programme. Research contracts for residents who have completed their specialization. 2- Support Valdecilla Programme. Supporting Idival´s research groups. 3- Research Managers Programme. Grant to train technicians in […]

Read more →

UC-IDIVAL participan en el mayor estudio sobre variaciones genéticas raras asociadas a la esquizofrenia

13 de December de 2016

20 Minutos 

Read more →

IDIVAL participates in the largest genetic study of schizophrenia

After analyzing more than 41,000 people (21,000 individuals with schizophrenia and 20,000 without it), the largest genomic study of schizophrenia to date has managed to isolate rare genetic variations that increase the risk of this disease. This study, recently published in Nature Genetics, has been conducted and led by the University of San Diego (USA), […]

Read more →

IDIVAL yields good results in the Health Research and Development Strategy 2016

The Health Research and Development Strategy, Institute of Health Carlos III, include a group of annual programmes to foster biomedical research which are essential to research in health in our country. These programmes include grants to develop research projects, other types of contracts and grants to participate in the Redes, consortiums and platforms of the […]

Read more →

Valdecilla renovará un segundo equipo de radioterapia con tecnología puntera

12 de December de 2016

El Diario Montañés

Read more →

21 December Third Session Progress Reports by Paula Iruzubieta

The following 21st of December will take place the third session of the Programme Progress Reports given by Paula Iruzubieta Coz, specialist in Digestive System at Marques de Valdecilla University Hospital.  The session will be about “The liver-specific deletion of the respiratory chain inhibitor MCJ attenuates NAFLD progression by enhancing hepatic beta-oxidation” and is summarized […]

Read more →

La AEC elige Valdecilla para formar a sus MIR en laparoscopia avanzada

9 de December de 2016

Diario Médico

Read more →